XPH

SPDR S&P Pharmaceuticals ETF
A

49
*Unless otherwise stated, data provided by FactSet.

XPH Fund Description

The SPDR S&P Pharmaceuticals ETF tracks an equal-weighted index of US pharmaceutical companies.

XPH Factset Analytics Insight

XPH offers equal-weighted exposure to roughly 30 US pharmaceutical companies, stretching across all market-cap sizes. XPH's weighting scheme causes it to be far less concentrated than the industry, which is dominated by a handful of mega-cap names like J&J, Pfizer and Merck. It also introduces a heavy tilt to mid- and small-caps, which makes for a rather volatile fund relative to the industry. XPH sees significant daily trading volume with small spreads, and underlying liquidity is excellent for block trades. It's also a very Efficient fund, with a low fee and tight tracking that lags by less than XPH's expense ratio. Overall, XPH is a solid way to capture a less concentrated version of the pharma market.

XPH MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of June 17, 2018 the SPDR S&P Pharmaceuticals ETF MSCI ESG Fund Quality Score is 4.61 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. XPH ranks in the 45th percentile within its peer group and in the 21st percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

XPH CHARTS AND PERFORMANCE

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:
PERFORMANCE [as of 06/15/18] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
XPH 6.76% 3.50% 2.71% 9.01% -7.93% 7.73% 13.58%
XPH (NAV) 6.68% 3.45% 2.71% 8.92% -7.93% 7.74% 13.56%
S&P Pharmaceuticals Select Industry Index 6.72% 3.53% 2.83% 9.13% -7.80% 7.90% 13.56%
Thomson Reuters US Pharmaceuticals 1.15% -2.77% -0.88% 4.00% 2.31% 10.39% 12.17%
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

XPH Top 10 Countries

XPH Top 10 Sectors

XPH Top 10 Holdings [View All]

XPH Summary Data

SPDR
06/19/06
Open-Ended Fund
0.35%
$348.71M
$3.11M
0.09%

XPH Portfolio Data

$44.53B
-38.59
2.00
0.58%
06/15/18
43

XPH Index Data

Equal
Market Cap
Thomson Reuters US Pharmaceuticals

XPH Portfolio Management

0.35%
-0.11%
-0.01%
-0.21%

XPH Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

XPH Fund Structure

Open-Ended Fund
No
Yes
100% / 0%
N/A
N/A
Low
Daily
Bats Book Viewer
TOP OF BOOK
LAST 10 TRADES
Bats BZX Real-time Quote -
Daily Spread
Premium/Discount
Volume

XPH Factset Analytics Block Liquidity

As of 06/18/18
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of XPH. XPH is rated a 5 out of 5.

XPH Tradability

75,312
$3.11M
48,427
$1.98M
0.09%
$0.04
-0.04%
0.12% / -0.35%
None
100.00%
50,000
0.97
0.01%
0.18%
430
$44.59
5

XPH Sector/Industry Breakdown


XPH
Segment Benchmark
80.11%
88.75%
12.34%
11.13%
2.22%
--
2.21%
--
2.20%
--
0.92%
--

XPH TOP 10 HOLDINGS[View All]

4.72%
4.65%
4.53%
4.49%
4.40%
4.23%
4.23%
4.03%
3.99%
3.96%
43.23%

XPH Countries


XPH
Segment Benchmark
100.00%
100.00%

XPH Regions


XPH
Segment Benchmark
100.00%
100.00%

XPH Economic Development


XPH
Segment Benchmark
100.00%
100.00%

XPH Performance Statistics

0.61
0.97
1.12
0.98
0.80%
Thomson Reuters US Pharmaceuticals

XPH MSCI ESG Ratings

4.61 / 10
44.50
20.74
--
4.91%
37.45

XPH BENCHMARK COMPARISON HOLDINGS

43
50
28
30.73%

XPH BENCHMARK COMPARISON SUMMARY


XPH
Segment Benchmark
43
50
$44.53B
$167.66B
-38.59
41.88
2.00
4.07
0.79%
2.41%
Medium
--

XPH BENCHMARK COMPARISON MARKET CAP SIZE


XPH
Segment Benchmark
37.35%
96.39%
11.86%
1.68%
47.01%
1.82%
3.77%
0.11%